Found 4 matching trials
Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP
N/AThe human monoclonal antibody (mAb), ansuvimab (mAb114), will be provided t...
Location
Multiple Locations
Prophylaxis Vaccine Antibodies Ebola
PHASE2* Three measures are currently being implemented to control Ebola outbreaks...
Location
Centre de Traitement Ebola de N'Zerekore
Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
PHASE2Background:
Ebola virus can cause serious illness or death. No medicines a...
Location
National Institutes of Health Clinical Center
Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults
PHASE1Background:
Ebola is a virus that has infected and killed people mostly in...
Location
National Institutes of Health Clinical Center